Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Prax Kinderpsychol Kinderpsychiatr ; 68(4): 253-270, 2019 May.
Artículo en Alemán | MEDLINE | ID: mdl-31044679

RESUMEN

"I Would Never have done it Without Coercion …" - Experiences with Coercion and Compulsion in a Family Psychiatric and Psychotherapeutic Day Clinic Coercion and compulsion have negative connotations, especially in psychiatric therapy. But in families, children are always also affected if parents do not want or are not able to make use of therapy. The avoidance of therapy can be a symptom of illness, e. g. separation anxiety. Perceived or real external coercion, e. g. from the youth welfare office or school, can be used to initially open up access to therapy and to allow parents to become capable of acting again. Coercion can initially reduce the ambivalence of the parents. The Family Therapeutic Centre (FaTZ) is a psychiatric and psychotherapeutic day clinic for parents and children. Family constellations are described in which initial coercion was a door-opener to therapy. During courses of treatment therapeutic alliances could be established, hope for positive change emerged, and the outcome was favourable. School avoidance of the child (e. g. due to separation anxiety) in combination with mentally ill parents is an exemplary constellation in which initial coercion can pave the way to therapy for families that otherwise wouldn't get access. Afterwards, voluntary cooperation should be intended, as the overriding objective is to reduce coercive measures to a minimum.


Asunto(s)
Coerción , Centros Comunitarios de Salud Mental , Terapia Familiar/métodos , Tratamiento Psiquiátrico Involuntario/métodos , Trastornos Mentales/terapia , Padres/psicología , Psicoterapia/métodos , Negativa del Paciente al Tratamiento/psicología , Adolescente , Ansiedad de Separación , Niño , Hijo de Padres Discapacitados/psicología , Terapia Familiar/ética , Humanos , Tratamiento Psiquiátrico Involuntario/ética , Trastornos Mentales/psicología , Cooperación del Paciente/psicología , Psicoterapia/ética
2.
J Appl Res Intellect Disabil ; 32(4): 932-941, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-30950144

RESUMEN

BACKGROUND: The move to community support for all people with intellectual disabilities is an aspiration with international significance. In this article, we draw on rich accounts from women with intellectual disabilities detained under the Mental Health Act (E&W) 1983 and staff at an National Health Service secure setting in England to explore how "moving on" is defined and perceived. METHODS: The study reports on an ethnographic study using the field-notes and the 26 semi-structured interviews with detained women and staff on three wards. RESULTS: We first explore staff conceptions of moving on, which include behavioural change and utilizing coping strategies. Then, we discuss the areas of analysis that women discussed: taking back responsibility, success in arranged relationships, acceptance of regime and resistance to progression. CONCLUSION: The concepts of moving on were not determined by the women but by the service. We recommend further research which explores women's own rehabilitation requirements.


Asunto(s)
Institucionalización , Discapacidad Intelectual/psicología , Discapacidad Intelectual/rehabilitación , Tratamiento Psiquiátrico Involuntario , Personas con Discapacidades Mentales/psicología , Personas con Discapacidades Mentales/rehabilitación , Adulto , Inglaterra , Femenino , Humanos , Legislación como Asunto , Programas Nacionales de Salud , Autonomía Personal , Investigación Cualitativa
3.
BMC Psychiatry ; 19(1): 37, 2019 01 23.
Artículo en Inglés | MEDLINE | ID: mdl-30674292

RESUMEN

BACKGROUND: Cardiometabolic health significantly impacts on the mortality of people with severe mental illness. Clozapine has the greatest efficacy for Treatment Resistant Schizophrenia (TRS) but the greatest negative impact on cardiometabolic health. Balancing the risks and benefits of treatment, dignity, autonomy, liberty, mental and physical health can be challenging, particularly when imposing interventions with potentially life threatening adverse events, such as clozapine. We describe the successful administration of clozapine in the face of myocardial infarction, pulmonary embolism and hyperlipidaemia resulting in the termination of long-term seclusion for a gentleman with TRS in high secure psychiatric services. CASE PRESENTATION: The impact of clozapine on a 44-year-old gentleman with TRS, extreme violence requiring physical restraint and long-term segregation, and numerous other significant physical health complications is described. He had metabolic syndrome; a poor diet, sedentary lifestyle, Body Mass Index (BMI) of 31.5, poorly controlled lipids and had smoked heavily since childhood. During preparations to initiate clozapine, he suffered a myocardial infarction and pulmonary embolism. His compliance with secondary prevention medications was poor due to paranoid persecutory and somatic delusions. Despite these concerns, nasogastric administration of clozapine was approved and prescribed within nine months of his myocardial infarction and a month from his pulmonary embolism but was ultimately not required. Accepting oral medication, his mental state made a rapid and dramatic improvement. After spending 1046 days in seclusion, this was terminated 94 days after clozapine initiation. He has been compliant with all medications for 24 months, had no incidents of violence or seclusion, and has been transferred to medium secure services. His physical health stabilised despite continuing to lead a sedentary lifestyle and remaining obese (BMI of 35). He developed hypertension, Type II Diabetes Mellitus and his triglycerides rose to 22.2 mmol/L in the same month after clozapine initiation. However, with pharmacological intervention, 24 months later these are controlled, and he has had no further thromboembolic events. CONCLUSIONS: We highlight that despite significant physical health concerns, clozapine can be successfully initiated and safely prescribed with a significantly positive effect on both the psychiatric and holistic care of patients with treatment resistant schizophrenia.


Asunto(s)
Clozapina/uso terapéutico , Hiperlipidemias/tratamiento farmacológico , Tratamiento Psiquiátrico Involuntario , Infarto del Miocardio/tratamiento farmacológico , Embolia Pulmonar/tratamiento farmacológico , Esquizofrenia/tratamiento farmacológico , Adulto , Antipsicóticos/uso terapéutico , Humanos , Hiperlipidemias/complicaciones , Hiperlipidemias/diagnóstico , Masculino , Síndrome Metabólico/complicaciones , Síndrome Metabólico/diagnóstico , Síndrome Metabólico/tratamiento farmacológico , Infarto del Miocardio/complicaciones , Infarto del Miocardio/diagnóstico , Embolia Pulmonar/complicaciones , Embolia Pulmonar/diagnóstico , Esquizofrenia/complicaciones , Esquizofrenia/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA